Published in Medical Letter on the CDC and FDA, March 11th, 2007
"We are extremely pleased that the FDA has taken this step as we continue our efforts to expand the label indication...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA